Fares Zahir - Profile and Investment Details

Investor Profile

Fares Zahir is a Venture Capital, Private Equity Firm based in Kuala Lumpur, Malaysia with a diverse investment portfolio that includes companies such as Liquidia Technologies, invendo medical, Aria CV, Gevo, P2 Science, Boston Neurosciences Inc, Rapid Micro Biosystems, Khazanah Nasional, UBS Investment Bank, InterVenn, Greenlight Biosciences, Iconic Therapeutics, Congenica, Imago BioSciences, Acutus Medical, ViewRay, OncoMyx Therapeutics, PrIME Biologics, . Over time, Fares Zahir has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Fares Zahir is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Genetics, Wellness, Women Founded, Investment Management, Trading Platform, Chemical, Life Science, Portfolio Management, Medical Technologies, Southeast Asian Founded, Startups, Venture Fundraising, Finance, Bioinformatics, Manufacturing, Biotechnology, Medical Devices, Drug Development, Clean Technology, Genomics, Productivity Software, Environmental Technology, Innovation, Reviews and Recommendations, Agriculture, Health Diagnostics, Regulatory Compliance, Oil and Gas, Renewable Energy, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Fares Zahir, as their portfolio suggests a familiarity and interest in this area.

Understanding Fares Zahir’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.